Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients

Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients

The molecular mechanisms underlying chemoresistance in some newly diagnosed multiple myeloma (MM) patients receiving standard therapies (lenalidomide, bortezomib, and dexamethasone) are poorly understood. Identifying clinically relevant gene networks associated with death due to MM may uncover novel...

Full description

Bibliographic Details
Main Authors: Adebayo, A.O (Author), Adebayo, O.O (Author), Barwick, B.G (Author), Boise, L.H (Author), Dammer, E.B (Author), Dill, C.D (Author), Griffen, T.L (Author), Jain, S. (Author), Lillard, J.W., Jr (Author), Ohandjo, A.Q (Author), Oseni, S.O (Author), Singh, R. (Author), Yan, F. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
chemoresistance
Kaplan–Meier
log-rank
multiple myeloma
ROC
WGCNA
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items